Koyfin Home > Directory > Health Care > Horizon Therapeutics > Price / Sales (ntm)

Horizon Therapeutics Price / Sales (ntm) Chart (HZNP)

Horizon Therapeutics annual/quarterly Price / Sales (ntm) from 2014 to 2020.
  • Horizon Therapeutics Price / Sales (ntm) for the quarter ending November 11, 2020 was 5.59 a -1.88% decrease of -0.11 year over year
  • Horizon Therapeutics Price / Sales (ntm) for the last 12 months ending November 11, 2020 was 5.59 a -1.88% decrease of -0.11 year over year
  • Horizon Therapeutics Annual Price / Sales (ntm) for 2020 was 5.59 a -1.34% decrease of -0.07 from 2019
  • Horizon Therapeutics Annual Price / Sales (ntm) for 2020 was 5.66 a 1.45% increase of 0.08 from 2019
  • Horizon Therapeutics Annual Price / Sales (ntm) for 2020 was 5.58 a -2.01% decrease of -0.11 from 2019
Other Valuation Metrics:
  • Horizon Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,337m a 17.35% increase of 406m year over year
  • Horizon Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.36 a 32.03% increase of 0.75 year over year
  • Horizon Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $3,487m a 7.74% increase of 270m year over year
View Chart On Koyfin

Quarterly HZNP Price / Sales (ntm) Data

11/20205.59
11/20205.66
11/20205.58
11/20205.69
11/20205.65
11/20205.77
11/20205.87
11/20206.07
11/20205.76
11/20205.68

Annual HZNP Price / Sales (ntm) Data

20205.59
20205.66
20205.58
20205.69
20205.65
20205.77
20205.87
20206.07
20205.76
20205.68